JOHNSON & JOHNSON

Johnson & Johnson is USA based company and it manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2019, Johnson & Johnson has 132,200 employees across 60 countries. Headquarters is in USA.

As on December-2019, The Company’s subsidiaries operate 97 manufacturing facilities occupying approximately 15.2 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

Johnson & Johnson annual sales - segment wise in 2019

Consumer segment annual sales in 2019 were 14,053 Million USD.
Pharmaceutical segment annual sales in 2019 were 45,572 Million USD.
Medical Devices segment annual sales in 2019 were 22,959 Million USD.

Johnson & Johnson annual revenue generated for period ending Dec-2020 is 82.58 Billion USD.

Johnson & Johnson annual net income generated for period ending Dec-2020 is 14.71 Billion USD.

Johnson & Johnson Dec-2020 ending annual Revenues in USA 43,133 Million USD
Johnson & Johnson Dec-2020 ending annual Revenues outside USA is 39,451 Million USD

Annual Results Summary:

Johnson & Johnson - Annual Results Summary - in Billion USD:

ANNUAL RESULTS	Total Revenue	Operating Income	Net Income	EPS (USD)
Dec-2021	93.77	24.54	20.87
Dec-2020	82.58	19.73	14.71	5.51
Dec-2019	82.05	20.08	15.12	5.63
Dec-2018	81.58	20.05	15.29	5.70
Dec-2017	76.45	18.71	1.30	0.48
Dec-2016	71.89		15.40	6.04
Dec-2015	70.07		15.41	5.57

Balance Sheet Summary

Johnson and Johnson - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Current Liabilities	Total Liabilities	Total Equity
Dec-2021	182,018	45,226	107,995	74,023
Dec-2020	174,894	42,493	111,616	63,278
Dec-2019	157,728	35,964	98,257	59,471
Dec-2018	152,954	31,230	93,202	59,752
Dec-2017	157,303	30,537	97,143	60,160
Jan-2017	141,208	26,287	70,790	70,418

Quarterly Results Summary:

Johnson and Johnson - Quarterly Results - Revenues and Profits - in Billion USD:

Quarter-Ending	Revenue	Net Profit	EPS (USD)
Dec-2021	24.80	4.73	1.80
Sep-2021	23.34	3.66	1.39
Jun-2021	23.31	6.27	2.48
Mar-2021	22.32	6.19	2.59
Dec-2020	22.47	1.73	0.65
Sep-2020	21.08	3.55	2.20
Jun-2020	18.33	3.62	1.36
Mar-2020	20.68	5.80	2.20
Dec-2019	20.74	4.01	1.52
Sep-2019	20.73	4.83	1.83
Jun-2019	20.56	5.61	2.07
Mar-2019	20.02	3.75	1.39
Dec-2018	20.39	3.04	1.12
Sep-2018	20.35	3.93	1.44

Institutional Investors

Top 25 Institutional Investors in JOHNSON & JOHNSON as on Jun-30-2020

Rank	OWNER NAME	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	231,747,508	-2,068,630	-0.89%	$34,092,376
2	BLACKROCK INC.	193,714,044	1,168,129	0.61%	$28,497,273
3	STATE STREET CORP	152,571,802	1,022,778	0.68%	$22,444,838
4	GEODE CAPITAL MANAGEMENT, LLC	39,573,737	608,581	1.56%	$5,821,692
5	BANK OF AMERICA CORP /DE/	34,678,931	2,523,518	7.85%	$5,101,618
6	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	34,574,792	0	0%	$5,086,298
7	NORTHERN TRUST CORP	33,972,792	386,631	1.15%	$4,997,737
8	BANK OF NEW YORK MELLON CORP	30,077,959	-1,719,123	-5.41%	$4,424,769
9	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	29,585,917	59,859	0.20%	$4,352,384
10	WELLINGTON MANAGEMENT GROUP LLP	28,769,995	-1,786,667	-5.85%	$4,232,354
11	NORGES BANK	28,375,314	18,223	0.06%	$4,174,292
12	JPMORGAN CHASE & CO	23,182,854	108,133	0.47%	$3,410,430
13	CAPITAL WORLD INVESTORS	23,112,974	1,916,985	9.04%	$3,400,150
14	WELLS FARGO & COMPANY/MN	21,683,561	343,950	1.61%	$3,189,869
15	MORGAN STANLEY	21,538,789	737,356	3.55%	$3,168,571
16	AMERIPRISE FINANCIAL INC	19,118,078	1,712,137	9.84%	$2,812,460
17	CAPITAL INTERNATIONAL INVESTORS	18,243,094	1,516,129	9.06%	$2,683,742
18	LEGAL & GENERAL GROUP PLC	17,381,285	-290,479	-1.64%	$2,556,961
19	NORDEA INVESTMENT MANAGEMENT AB	17,222,162	8,062,204	88.02%	$2,533,552
20	PRICE T ROWE ASSOCIATES INC /MD/	17,086,490	-1,914,763	-10.08%	$2,513,594
21	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	16,424,663	-145,704	-0.88%	$2,416,232
22	FMR LLC	16,037,760	-1,105,456	-6.45%	$2,359,315
23	NUVEEN ASSET MANAGEMENT, LLC	15,340,211	-453,360	-2.87%	$2,256,698
24	ROYAL BANK OF CANADA	14,711,443	358,633	2.50%	$2,164,200
25	DEUTSCHE BANK AG\	14,134,825	-90,690	-0.64%	$2,079,374

Comments

JOHNSON & JOHNSON Dec-2020 Ending Quarter (Q4) HIGHLIGHTS

2020 Fourth-Quarter Sales of 22.5 Billion USD reflecting growth of 8.3%.
2020 Fourth-Quarter Net Income of 1.73 Billion USD reflecting decline of 56.7%.

Johnson & Johnson Dec-2020 ending quarterly Revenues in USA 11,809 Million USD
Johnson & Johnson Dec-2020 ending quarterly Revenues outside USA is 10,666 Million USD

Sun, 31/01/2021 - 06:11